Skip to main content
Log in

Docetaxel-loaded liposomes: preparation, pH sensitivity, Pharmacokinetics, and tissue distribution

  • Published:
Journal of Zhejiang University SCIENCE B Aims and scope Submit manuscript

Abstract

Docetaxel (DTX), as a member of taxoid family, has been widely used in the treatment of cancers. The present study prepared pH-sensitive DTX-loaded liposomes (DTX-Lips) by thin-film dispersion method and various physico-chemical and morphological properties were examined. The pH sensitivity of in vitro DTX release and the in vivo pharmacokinetics and tissue distribution using Kunming mice were also investigated. The mean particle size and zeta potential of DTX liposomes were (277±2) nm and (−32.60±0.26) mV, respectively. Additionally, in vitro drug release study showed that the cumulative release rate was 1.3 times more at pH 5.0 than at pH 7.4, suggesting a pH-dependent release ability of DTX-Lips. Pharmacokinetic and pharmaceutical studies in comparison with Duopafei® showed that the half-time period (t 1/2) and area under the curve (AUC) of DTX-Lips in mouse plasma were 1.8 times longer and 2.6 times higher, respectively, and that DTX-Lips selectively accumulated in macrophage-rich organs such as liver and spleen. These results together suggest that the DTX-Lips could be a promising formulation for the clinical administration of DTX.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Baker, J., Ajani, J., Scotté, F., Winther, D., Martin, M., Aapro, M.S., von Minckwitz, G., 2009. Docetaxel-related side effects and their management. Eur. J. Oncol. Nurs., 13(1):49–59. [doi:10.1016/j.ejon.2008.10.003]

    Article  PubMed  Google Scholar 

  • Bissery, M.C., 1995. Preclinical pharmacology of docetaxel. Eur. J. Cancer, 31(S4):S1–S6. [doi:10.1016/0959-8049 (95)00357-O]

    Article  Google Scholar 

  • Chu, C.J., Dijkstra, J., Lai, M.Z., Hong, K., Szoka, F.C., 1990. Efficiency of cytoplasmic delivery by pH-sensitive liposomes to cells in culture. Pharm. Res., 7(8):824–834. [doi:10.1023/A:1015908831507]

    Article  PubMed  CAS  Google Scholar 

  • Connor, J., Huang, L., 1985. Efficient cytoplasmic delivery of a fluorescent dye by pH-sensitive immunoliposomes. J. Cell Biol., 101(2):582–589. [doi:10.1083/jcb.101.2.582]

    Article  PubMed  CAS  Google Scholar 

  • Ducat, E., Deprez, J., Peulen, O., Evrard, B., Piel, G., 2010. Cellular uptake of long-circulating pH sensitive liposomes: evaluation of the liposome and its encapsulated material penetration in cancer cells. Drug Discov. Today, 15(23-24):1083. [doi:10.1016/j.drudis.2010.09.362]

    Article  Google Scholar 

  • Engels, F.K., Sparreboom, A., Mathot, R.A., Verweij, J., 2005. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review. Br. J. Cancer, 93(2):173–177. [doi:10.1038/sj.bjc.6602698]

    Article  PubMed  CAS  Google Scholar 

  • Friedenberg, W.R., Graham, D., Greipp, P., Blood, E., Winston, R.D., 2003. The treatment of multiple myeloma with docetaxel (an ECOG study). Leuk. Res., 27(8):751–754. [doi:10.1016/S0145-2126(02)00344-2]

    Article  PubMed  CAS  Google Scholar 

  • Gelmon, K., 1994. The taxoids: paclitaxel and docetaxel. Lancet, 344(8932):1267–1272. [doi:10.1016/S0140-6736 (94)90754-4]

    Article  PubMed  CAS  Google Scholar 

  • Grant, D.S., Williams, T.L., Zahaczewsky, M., Dicker, A.P., 2003. Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere). Int. J. Cancer, 104(1):121–129. [doi:10.1002/ijc.10907]

    Article  PubMed  CAS  Google Scholar 

  • Hait, W.N., Rublin, E., Alli, E., Goodin, S., 2007. Tubulin targeting agents. Update on Cancer Therapeutics., 2(1):1–18. [doi:10.1016/j.uct.2006.10.001].

    Article  Google Scholar 

  • Hanauske, A.R., Depenbrock, H., Shirvani, D., Rastetter, J., 1994. Effects of the microtubule-disturbing agents docetaxel (Taxotere®), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro. Eur. J. Cancer, 30(11):1688–1694. [doi:10.1016/0959-8049(94)00338-6]

    Article  Google Scholar 

  • Herbst, R.S., Khuri, F.R., 2003. Mode of action of docetaxel-a basis for combination with novel anticancer agents. Cancer Treat. Rev., 29(5):407–415. [doi:10.1016/S0305-7372(03)00097-5]

    Article  PubMed  CAS  Google Scholar 

  • Hiraka, K., Kanehisa, M., Tamai, M., Asayama, S., Nagaoka, S., Oyaizu, K., Yuasa, M., Kawakami, H., 2008. Preparation of pH-sensitive liposomes retaining SOD mimic and their anticancer effect. Colloids Surf. B Biointerfaces, 67(1):54–58. [doi:10.1016/j.colsurfb.2008.07.014]

    Article  PubMed  CAS  Google Scholar 

  • Immordino, M.L., Brusa, P., Arpicco, S., Stella, B., Dosio, F., Catte, L., 2003. Preparation, characterization, cytotoxicity and pharmacokinetics of liposomes containing docetaxel. J. Control. Release, 91(3):417–429. [doi:10.1016/S0168-3659(03)00271-2]

    Article  PubMed  CAS  Google Scholar 

  • Izquierdo, M.A., García, M., Pontón, J.L., Martínez, M., Valentí, V., Navarro, M., Gil, M., Cardenal, F., Mesía, R., Pérez, X., Salazar, R., Germà-Lluch, J.R., 2006. A phase I clinical and pharmacokinetic study of paclitaxel and docetaxel given in combination in patients with solid tumours. Eur. J. Cancer, 42(12):1789–1796. [doi:10.1016/j.ejca.2005.10.031]

    Article  PubMed  CAS  Google Scholar 

  • Kale, A.A., Torchilin, V.P., 2010. Environment-responsive multifunctional liposomes. Methods Mol. Biol., 605: 213–242. [doi:10.1007/978-1-60327-360-2_15]

    Article  PubMed  CAS  Google Scholar 

  • Li, J., Yu, H., Li, S., Wang, G.J., 2010. Enhanced distribution and extended elimination of glycyrrhetinic acid in mice liver by mPEG-PLA modified (mPEGylated) liposome. J. Pharm. Biomed. Anal., 51(5):1147–1153. [doi:10.1016/j. jpba.2009.11.005]

    Article  PubMed  CAS  Google Scholar 

  • Lian, T., Ho, R.J., 2001. Trends and developments in liposome drug delivery systems. J. Pharm. Sci., 90(6):667–680. [doi:10.1002/jps.1023]

    Article  PubMed  CAS  Google Scholar 

  • Maurer, N., Fenske, D.B., Cullis, P.R., 2001. Developments in liposomal drug delivery Systems. Expert. Opin. Biol. Ther., 1(6):923–947. [doi:10.1517/14712598.1.6.923]

    Article  PubMed  CAS  Google Scholar 

  • Muthu, M.S., Singh, S., 2009. Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. Nanomedicine, 4(1):105–118. [doi:10.2217/17435889.4.1.105]

    Article  PubMed  CAS  Google Scholar 

  • Parveen, S., Misra, R., Sahoo, S.K., 2012. Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine, 8(2):147–166. [doi:10.1016/j. nano.2011.05.016]

    Article  PubMed  CAS  Google Scholar 

  • Philippot, J.R., Mutaftschiev, S., Liautard. J.P., 1985. Extemporaneous preparation of large unilamellar liposomes. Biochim. Biophys. Acta., 821(1):79–84. [doi:10.1016/0005-2736(85)90156-7]

    Article  PubMed  CAS  Google Scholar 

  • Posner, M.R, Lefebvre, J.L., 2003. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck. Br. J. Cancer, 88(1):11–17. [doi:10. 1038/sj.bjc.6600685]

    Article  PubMed  CAS  Google Scholar 

  • Rowinsky, E.K., 1997. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 48:353-374. [doi:10.1146/annurev. med.48.1.353].

    Google Scholar 

  • Sánchez, M., Aranda, F.J., Teruel, J.A., Ortiz, A., 2011. New pH-sensitive liposomes containing phosphatidylethanolamine and a bacterial dirhamnolipid. Chem. Phys. Lipids, 164(1):16–23. [doi:10.1016/j.chemphyslip.20 10.09.008]

    Article  PubMed  Google Scholar 

  • Straubinger, R.M., Düzgünes, N., Papahadjopoulos, D., 1985. pH-sensitive liposomes mediate cytoplasmic delivery of encapsulated macromolecules, FEBS Lett., 179(1):148–154. [doi:10.1016/0014-5793(85)80210-6]

    Article  PubMed  CAS  Google Scholar 

  • Torchilin, V.P., 2005. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug Discov., 4(2):145–160. [doi:10.1038/nrd1632]

    Article  PubMed  CAS  Google Scholar 

  • Torchilin, V.P., Zhou, F., Huang, L., 1993. pH-sensitive liposomes. J. Liposome Res., 3(2):201–255. [doi:10.3109/08982109309148213]

    Article  CAS  Google Scholar 

  • Torchilin, V.P., Lukyanov, A.N., Klibanov, A.L., Omelyanenko, V.G., 1992. Interaction between oleic acid-containing pH-sensitive and plain liposomes. Fluorescent spectroscopy studies. FEBS Lett., 305(3):185–188. [doi:10. 1016/0014-5793(92)80663-2]

    Article  PubMed  CAS  Google Scholar 

  • Tosi, G., Vergoni, A.V., Ruozi, B., Bondioli, L., Badiali, L., Rivasi, F., Costantino, L., Forni, F., Vandelli, M.A., 2010. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: in vivo pharmacological evidence and biodistribution. J. Control. Release, 145(1):49–57. [doi:10.1016/j.jconrel. 2010.03.008]

    Article  PubMed  CAS  Google Scholar 

  • Vassilomanolakis, M., Koumakis, G., Barbounis, V., Demiri, M., Panopoulos, C., Chrissohoou, M., Apostolikas, N., Efremidis, A.P., 2005. First-line chemotherapy with docetaxel and cisplatin in metastatic breast cancer. Breast, 14(2):136–141. [doi:10.1016/j.breast.2004.08.017]

    Article  PubMed  CAS  Google Scholar 

  • Yang, F., Jin, C., Jiang, Y., Li, J., Di, Y., Ni, Q., Fu, D., 2011. Liposome based delivery systems in pancreatic cancer treatment: from bench to bedside. Cancer Treat. Rev., 37(8):633–642. [doi:10.1016/j.ctrv.2011.01.006]

    Article  PubMed  CAS  Google Scholar 

  • Yuba, E., Kojima, C., Harada, A., Tana, Watarai, S., Kono., K., 2010. pH-sensitive fusogenic polymer-modified liposomes as a carrierof antigenic proteins for activation of cellular immunity. Biomaterials, 31(5):943–951. [doi:10.1016/j.biomaterials.2009.10.006]

    Article  PubMed  CAS  Google Scholar 

  • Zhang, P., Ling, G., Pan, X., Sun, J., Zhang, T., Pu, X., Yin, S., He, Z., 2012. Novel nanostructured lipid-dextran sulfate hybrid carriers overcome tumor multidrug resistance of mitoxantrone hydrochloride. Nanomedicine, 8(2):185–193. [doi:10.1016/j.nano.2011.06.007]

    Article  PubMed  Google Scholar 

  • Zhao, L., Wei, Y.M., Zhong, X.D., Liang, Y., Zhang, X.M., Li, W., Li, B.B., Wang, Y., Yu, Y., 2009. PK and tissue distribution of docetaxel in rabbits after i.v. administration of liposomal and injectable formulations. J. Pharm. Biomed. Anal., 49(4):989–996. [doi:10.1016/j.jpba.2009.01.016]

    Article  PubMed  CAS  Google Scholar 

  • Zignani, M., Drummond, D.C., Meyer, O., Hong, K., Leroux, J.C., 2000. In vitro characterization of a novel polymeric-based pH-sensitive liposome system. Biochim. Biophs. Acta, 1463(2):383–394. [doi:10.1016/S0005-2736(99)00234-5]

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gui-mei Lin.

Additional information

Project supported by the Independent Innovation Foundation of Shandong University, China (No. 2010TS041) and the Shandong Provincial Special Funds for Postdoctoral Innovative Projects, China (No. 201003069)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, H., Li, Ry., Lu, X. et al. Docetaxel-loaded liposomes: preparation, pH sensitivity, Pharmacokinetics, and tissue distribution. J. Zhejiang Univ. Sci. B 13, 981–989 (2012). https://doi.org/10.1631/jzus.B1200098

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1631/jzus.B1200098

Key words

CLC number

Navigation